食物アレルギー診断薬・治療薬市場：製品タイプ、技術、供給源、成分、エンドユーザー別-2025-2030年の世界予測

食物アレルギー診断薬・治療薬市場の2023年の市場規模は58億6,000万米ドルで、2024年には64億3,000万米ドルに達すると予測され、CAGR 10.35％で成長し、2030年には116億9,000万米ドルに達すると予測されています。

食物アレルギーの診断と治療市場は、診断テストから治療ソリューションまで、食物アレルギーの特定と管理を目的とした製品とサービスを主に包含しています。これらの技術の必要性は、食物アレルギーの世界の蔓延から生じており、何百万人もの生活に影響を与え、生活の質を高めヘルスケアコストを削減するために正確な診断と効果的な治療が必要となっています。アプリケーションは、体外および分子アレルゲン診断が使用される臨床現場から、個人消費者用の家庭用検査キットまで多岐にわたる。最終用途の範囲には、アレルギー・免疫学を専門とする病院、診療所、研究機関が含まれます。主な成長要因としては、食物アレルギーに対する意識の高まり、バイオテクノロジーの発展、研究開発投資の増加などが挙げられます。最新の潜在的機会は、新規生物製剤、低アレルギー性食品、および個々のアレルゲン・プロファイルに合わせた個別化医療アプローチの開発にあります。また、患者教育や治療へのアドヒアランスのためにデジタルヘルスの進歩を利用することも、大きな成長の道を示しています。

しかし、市場は、高度な診断検査にかかる高コスト、規制上のハードル、診断と治療の標準化を複雑にしている食物アレルギーの症状のばらつきといった限界に直面しています。また、認知度やインフラの不足による発展途上地域での採用の遅れも大きな課題となっています。イノベーションを促進するために、企業は費用対効果の高い非侵襲的診断技術の開発、食物アレルゲン表示の強化、アレルギーの動向と治療効果を予測するためのAIと機械学習への投資に注力することができます。さらに、腸内マイクロバイオーム治療法を探求するための研究機関との連携は、有望な知見を提供する可能性があります。課題はあるもの、市場はダイナミックであり、重要な研究開発活動と革新的ソリューションの着実な流入が特徴的です。より正確な診断と効果的な治療法に対する需要が高まるにつれ、業界は拡大に向かっており、テクノロジーと戦略的パートナーシップを活用する企業が競争上の優位性を獲得する可能性が高いです。

市場力学：急速に進化する食物アレルギー診断薬・治療薬市場の主要市場インサイトを公開

食物アレルギー診断薬・治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 小児および成人におけるアレルギー疾患の増加
  • 食物アレルギー診断における団体による資金の増加
  • 体外診断用血液検査に対する患者の需要の増加
• 市場抑制要因
  • 食物アレルギー検査法の認知度低下と実施率の低下
• 市場機会
  • 食物アレルギー診断法および治療法における継続的な技術進歩
  • 医薬品開発のための研究開発イニシアチブの増加
• 市場の課題
  • 食物アレルギー診断・治療薬に関する厳しい規制枠組み

ポーターの5つの力：食物アレルギー診断薬・治療薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：食物アレルギー診断薬・治療薬市場における外部からの影響の把握

外部マクロ環境要因は、食物アレルギー診断薬・治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析食物アレルギー診断薬・治療薬市場における競合情勢の把握

食物アレルギー診断薬・治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス食物アレルギー診断薬・治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、食物アレルギー診断薬・治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨食物アレルギー診断薬・治療薬市場における成功への道筋を描く

食物アレルギー診断薬・治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 小児および成人におけるアレルギー疾患の発生率増加
    • 食物アレルギー診断における団体による資金増加
    • 体外診断用血液検査に対する患者の需要増加
  • 抑制要因
    • 食品アレルギー検査方法の認知度が低く、実施も少ない
  • 機会
    • 食物アレルギーの診断と治療における継続的な技術進歩
    • 医薬品開発のための研究開発の取り組みの増加
  • 課題
    • 食物アレルギーの診断と治療に関する厳格な規制枠組み
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 食物アレルギー診断薬・治療薬市場：製品タイプ別

• 診断テストの種類
  • In vitro（体外）
  • 生体内/皮膚
    • パッチテスト
    • 皮膚プリックテスト
• 治療の種類
  • 抗ヒスタミン薬
  • エピネフリン自動注射器

第7章 食物アレルギー診断薬・治療薬市場：技術別

• 酵素免疫測定法
• ポリメラーゼ連鎖反応

第8章 食物アレルギー診断薬・治療薬市場：ソース別

• 卵
• 魚
• ミルク
• ピーナッツ
• 貝
• 大豆
• 木の実
• 小麦

第9章 食物アレルギー診断薬・治療薬市場：コンポーネント別

• 消耗品
• 機器
• サービス

第10章 食物アレルギー診断薬・治療薬市場：エンドユーザー別

• 学術調査機関
• 診断研究所
• 病院・クリニック

第11章 南北アメリカの食物アレルギー診断薬・治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の食物アレルギー診断薬・治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの食物アレルギー診断薬・治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • アレフファーム、VBLセラピューティクス施設の買収とESCOアスターとの提携により生産能力を向上
  • ジェラス・パス・ラボ、インドでのアレルギー検査の展開を拡大
  • ディーサイドの会社が食品アレルギー診断で米国特許を取得
  • 「サーモフィッシャーの小麦とゴマのアレルギー血液検査がFDAの承認を獲得
  • CoreRx, Inc.がAimmune Therapeuticsのピーナッツアレルギー治療の商業供給契約を発表-CoreRx（R）
  • ランテウス、前立腺がんの臨床開発を支援するための提携を発表
  • アレルギーセラピューティクス、ピーナッツアレルギーワクチン候補の製造にAGCバイオロジクスを選択
  • FDA、ピーナッツアレルギー治療薬候補のIND申請を承認
  • Praetura Venturesが食品アレルギー診断会社に290万ポンドの投資を主導
  • Ukko、AIで食物アレルギーに対処するために4,000万米ドルを調達
• 戦略分析と提言

企業一覧

• 7 Drops Diagnostics, Inc.
• ACON Laboratories, Inc.
• AESKU.GROUP GmbH
• ALK-Abello A/S
• Allergy Therapeutics PLC
• Alpha Laboratories
• Apexhealth by Acecgt Diagnostic Limited
• Apollo Diagnostics
• Aster Clinical Lab LLP
• Astra Biotech GmbH
• bioMerieux SA
• Cerascreen GmbH
• Eurofins Scientific（Ireland）Limited
• EUROIMMUN Medizinische Labordiagnostika AG
• HollisterStier Allergy by Jubilant Pharma Holdings Inc.
• HYCOR Biomedical
• Indoor Biotechnologies, Inc.
• Laboratory Corporation of America Holdings.
• Lincoln Diagnostics, Inc.
• Medeca Pharma AB
• Microbac Laboratories, Inc.
• Minaris Medical America, Inc.
• Neogen Corporatio
• Nestle Health Science
• Omega Diagnostics Group PLC
• Prota Therapeutics Pty. Ltd.
• Quest Consumer Inc.
• R-Biopharm AG
• Romer Labs Division Holding GmbH
• ROXALL Medizin GmbH
• Siemens AG
• STALLERGENES GREER International AG
• Tecan Trading AG
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET DYNAMICS
• TABLE 7. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VITRO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PATCH TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SKIN PRICK TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY EPINEPHRINE AUTO-INJECTOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY EGGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY MILK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PEANUTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SHELLFISH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TREE NUTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY WHEAT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 66. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 67. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 70. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 71. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 78. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 87. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 96. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 100. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 101. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 104. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 105. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 108. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 109. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 112. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 113. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 116. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 117. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 120. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 121. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 124. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 125. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 128. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 129. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 132. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 133. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 136. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 137. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 140. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 141. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 144. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 145. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 148. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 149. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 152. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 153. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 155. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 156. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 157. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 160. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 161. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 172. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 173. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 176. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 177. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 180. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 181. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 184. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 185. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 187. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 188. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 189. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 192. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 193. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 203. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 205. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 206. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 209. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 210. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 212. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 213. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 214. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 215. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 216. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 217. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 218. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 220. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 221. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 222. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 223. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 225. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 226. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 228. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 229. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 230. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 233. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 234. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 236. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 237. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 238. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 239. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 240. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 241. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 242. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 243. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 244. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 245. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 246. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 247. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 248. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 249. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 250. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 251. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 252. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 253. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 254. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 255. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 256. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 257. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 258. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 259. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 260. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 261. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 262. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 263. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 264. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 265. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 266. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 267. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 268. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 269. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 270. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 271. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 272. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 273. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 274. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 275. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 276. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 277. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
• TABLE 278. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 279. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 280. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 281. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 282. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 283. POLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 284. POLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
• TABLE 285. POLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-203

The Food Allergy Diagnostics & Therapeutics Market was valued at USD 5.86 billion in 2023, expected to reach USD 6.43 billion in 2024, and is projected to grow at a CAGR of 10.35%, to USD 11.69 billion by 2030.

The food allergy diagnostics and therapeutics market primarily encompasses products and services aimed at identifying and managing food allergies, from diagnostic tests to therapeutic solutions. The necessity for these technologies arises from a growing prevalence of food allergies globally, impacting millions of lives and necessitating accurate diagnostics and effective treatments to enhance quality of life and reduce healthcare costs. Applications range from clinical settings, where in vitro and molecular allergen diagnostics are used, to at-home testing kits for individual consumer use. The end-use scope includes hospitals, clinics, and research institutions focused on allergy and immunology. Key growth influencers include rising awareness of food allergies, advancements in biotechnology, and increasing investments in research and development. The latest potential opportunities lie in the development of novel biologics, hypoallergenic food products, and personalized medicine approaches tailored to individual allergen profiles. Exploiting advancements in digital health for patient education and adherence to therapies also presents substantial growth avenues.

However, the market faces limitations such as high costs of advanced diagnostic tests, regulatory hurdles, and variability in food allergy manifestations that complicate standardization in diagnostics and treatment. Slow adoption in developing regions due to lack of awareness and infrastructure also poses significant challenges. To foster innovation, businesses can focus on developing cost-effective, non-invasive diagnostic technologies, enhancing food allergen labeling, and investing in AI and machine learning to predict allergy trends and treatment effectiveness. Additionally, collaboration with research institutions to explore gut microbiome therapies could offer promising insights. Despite its challenges, the market is dynamic, marked by significant research and development activities and a steady influx of innovative solutions. As the demand for more precise diagnosis and effective therapeutics grows, the industry is poised for expansion, with companies that leverage technology and strategic partnerships likely to gain a competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Food Allergy Diagnostics & Therapeutics Market

The Food Allergy Diagnostics & Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidences of allergic conditions among pediatric and adult populations
  • Increasing funds by organizations in food allergy diagnostics
  • Rising patient demand for in vitro diagnostic blood tests
• Market Restraints
  • Limited awareness and less implementation of food allergic testing methods
• Market Opportunities
  • Ongoing technological advancements in food allergy diagnostics and therapeutics
  • Increasing number of research and development initiatives for the development of drugs
• Market Challenges
  • Stringent regulatory framework for food allergy diagnostics and therapeutics

Porter's Five Forces: A Strategic Tool for Navigating the Food Allergy Diagnostics & Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Food Allergy Diagnostics & Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Food Allergy Diagnostics & Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Food Allergy Diagnostics & Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Food Allergy Diagnostics & Therapeutics Market

A detailed market share analysis in the Food Allergy Diagnostics & Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Food Allergy Diagnostics & Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Food Allergy Diagnostics & Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Food Allergy Diagnostics & Therapeutics Market

A strategic analysis of the Food Allergy Diagnostics & Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Food Allergy Diagnostics & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 7 Drops Diagnostics, Inc., ACON Laboratories, Inc., AESKU.GROUP GmbH, ALK-Abello A/S, Allergy Therapeutics PLC, Alpha Laboratories, Apexhealth by Acecgt Diagnostic Limited, Apollo Diagnostics, Aster Clinical Lab LLP, Astra Biotech GmbH, bioMerieux SA, Cerascreen GmbH, Eurofins Scientific (Ireland) Limited, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy by Jubilant Pharma Holdings Inc., HYCOR Biomedical, Indoor Biotechnologies, Inc., Laboratory Corporation of America Holdings., Lincoln Diagnostics, Inc., Medeca Pharma AB, Microbac Laboratories, Inc., Minaris Medical America, Inc., Neogen Corporatio, Nestle Health Science, Omega Diagnostics Group PLC, Prota Therapeutics Pty. Ltd., Quest Consumer Inc., R-Biopharm AG, Romer Labs Division Holding GmbH, ROXALL Medizin GmbH, Siemens AG, STALLERGENES GREER International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Food Allergy Diagnostics & Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Diagnostic Tests Type and Therapeutic Treatment Type. The Diagnostic Tests Type is further studied across In Vitro and In Vivo/Skin. The In Vivo/Skin is further studied across Patch Test and Skin Prick Test. The Therapeutic Treatment Type is further studied across Antihistamines and Epinephrine Auto-Injector.
• Based on Technology, market is studied across Enzyme-Linked Immunosorbent Assay and Polymerase Chain Reaction.
• Based on Source, market is studied across Eggs, Fish, Milk, Peanuts, Shellfish, Soy, Tree Nuts, and Wheat.
• Based on Component, market is studied across Consumables, Instruments, and Services.
• Based on End-User, market is studied across Academic Research Institutes, Diagnostics Laboratories, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of allergic conditions among pediatric and adult populations
    • 5.1.1.2. Increasing funds by organizations in food allergy diagnostics
    • 5.1.1.3. Rising patient demand for in vitro diagnostic blood tests
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness and less implementation of food allergic testing methods
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing technological advancements in food allergy diagnostics and therapeutics
    • 5.1.3.2. Increasing number of research and development initiatives for the development of drugs
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory framework for food allergy diagnostics and therapeutics
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Food Allergy Diagnostics & Therapeutics Market, by Product Type

• 6.1. Introduction
• 6.2. Diagnostic Tests Type
  • 6.2.1. In Vitro
  • 6.2.2. In Vivo/Skin
    • 6.2.2.1. Patch Test
    • 6.2.2.2. Skin Prick Test
• 6.3. Therapeutic Treatment Type
  • 6.3.1. Antihistamines
  • 6.3.2. Epinephrine Auto-Injector

7. Food Allergy Diagnostics & Therapeutics Market, by Technology

• 7.1. Introduction
• 7.2. Enzyme-Linked Immunosorbent Assay
• 7.3. Polymerase Chain Reaction

8. Food Allergy Diagnostics & Therapeutics Market, by Source

• 8.1. Introduction
• 8.2. Eggs
• 8.3. Fish
• 8.4. Milk
• 8.5. Peanuts
• 8.6. Shellfish
• 8.7. Soy
• 8.8. Tree Nuts
• 8.9. Wheat

9. Food Allergy Diagnostics & Therapeutics Market, by Component

• 9.1. Introduction
• 9.2. Consumables
• 9.3. Instruments
• 9.4. Services

10. Food Allergy Diagnostics & Therapeutics Market, by End-User

• 10.1. Introduction
• 10.2. Academic Research Institutes
• 10.3. Diagnostics Laboratories
• 10.4. Hospitals & Clinics

11. Americas Food Allergy Diagnostics & Therapeutics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Food Allergy Diagnostics & Therapeutics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Food Allergy Diagnostics & Therapeutics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Aleph Farms Increases Production Capabilities With VBL Therapeutics Facility Acquisition And ESCO Aster Partnership
  • 14.3.2. Jerath Path Labs expands the reach in India in allergy-testing
  • 14.3.3. Deeside firm secures US patent for food allergy diagnostics
  • 14.3.4. "Thermo Fisher's Wheat And Sesame Allergy Blood Tests Earn FDA Nod
  • 14.3.5. CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics' Investigational Peanut Allergy Treatment - CoreRx(R)
  • 14.3.6. Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development
  • 14.3.7. Allergy Therapeutics Selects AGC Biologics to Manufacture Peanut Allergy Vaccine Candidate
  • 14.3.8. FDA approves IND application for peanut allergy drug candidate
  • 14.3.9. Praetura Ventures leads £2.9m investment in food allergy diagnostic company
  • 14.3.10. Ukko raises $40 million to address food allergies with AI
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 7 Drops Diagnostics, Inc.
• 2. ACON Laboratories, Inc.
• 3. AESKU.GROUP GmbH
• 4. ALK-Abello A/S
• 5. Allergy Therapeutics PLC
• 6. Alpha Laboratories
• 7. Apexhealth by Acecgt Diagnostic Limited
• 8. Apollo Diagnostics
• 9. Aster Clinical Lab LLP
• 10. Astra Biotech GmbH
• 11. bioMerieux SA
• 12. Cerascreen GmbH
• 13. Eurofins Scientific (Ireland) Limited
• 14. EUROIMMUN Medizinische Labordiagnostika AG
• 15. HollisterStier Allergy by Jubilant Pharma Holdings Inc.
• 16. HYCOR Biomedical
• 17. Indoor Biotechnologies, Inc.
• 18. Laboratory Corporation of America Holdings.
• 19. Lincoln Diagnostics, Inc.
• 20. Medeca Pharma AB
• 21. Microbac Laboratories, Inc.
• 22. Minaris Medical America, Inc.
• 23. Neogen Corporatio
• 24. Nestle Health Science
• 25. Omega Diagnostics Group PLC
• 26. Prota Therapeutics Pty. Ltd.
• 27. Quest Consumer Inc.
• 28. R-Biopharm AG
• 29. Romer Labs Division Holding GmbH
• 30. ROXALL Medizin GmbH
• 31. Siemens AG
• 32. STALLERGENES GREER International AG
• 33. Tecan Trading AG
• 34. Thermo Fisher Scientific Inc.